Management

Christopher J. Moreau

Christopher J. Moreau

Chief Executive Officer
Mr. Moreau is the CEO of Algernon Pharmaceuticals Inc. and a member of the company's board of directors. With over 30 years of executive management experience overall, including 15 years in CEO roles, he has proven achievements in operations management, acquisitions, licensing, and integration. Mr. Moreau also has significant experience managing biotechnology research programs, and a deep expertise in business development and capital markets, having raised more than $50 million. He has also been featured on numerous business television and social media interviews, and is a highly skilled communicator and sought-after speaker, recently appearing as a guest Lecturer for the University of East London, Pharmacology program.
Christopher Bryan, PhD

Christopher Bryan, PhD

Vice President Research & Operations
Dr. Christopher Bryan graduated from the University of Toronto, with a PhD in organic chemistry and brings significant skills and experience to Algernon. His background as a scientist and senior manager includes the synthesis of hundreds of novel small molecules as potential therapeutic agents, the coordination of regional commercial teams and internal departments (i.e., marketing, R&D, manufacturing, sales and regulatory affairs), and the management of multiple strategic relationships including those involving key opinion leaders. He also has extensive experience in scientific writing, data analysis and literature review.
James Kinley, CPA, CA

James Kinley, CPA, CA

Chief Financial Officer
Mr. Kinley is a Certified Professional Accountant (“CPA, CA”) with over 15 years of experience in building, leading, and advising corporations through their daily operations as well as on complex restructurings, mergers, acquisitions, and capital markets transactions. He is also accomplished in structuring and negotiating favorable terms with commercial and investment banks. He was previously the CFO for Medicure Inc. (TSX-V: MPH), another Canadian publicly traded pharmaceutical company, a position he held for nearly 10 years.
Dr. Ahmad Khalil MD PhD

Dr. Ahmad Khalil MD PhD

Medical Director
Dr. Khalil has extensive biopharmaceutical experience bringing drugs into clinical trials over the past 20 years, acting in the capacities of Medical Director, Medical Monitor, and Clinical Consultant for a variety of companies. He is a member of the Harvard Medical School Postgraduate Association, the Canadian Medical Association, the University of Montreal General Professor Syndicate, and the American Heart Association Professional Membership & Cardiovascular Sciences Councils.
Share via
Copy link
Powered by Social Snap